← Leaderboards
Hatice Sen
National Eye Institute
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Eye Institute
Same institution · by research overlap
Others in their field
Top investigators on “Inflammatory”
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Edward A Dennis · University Of California, San Diego$72,701,136
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Randall J Bateman · Washington University$62,939,456
- Paul M. Ridker · Brigham And Women'S Hospital$56,179,451
- Keri Hammel · The Emmes Company, Llc$53,700,408
Research focus
InflammatoryUveitisEnrollmentParticipantImmunosuppressive AgentsVisitBlindnessDesignInflammationVisual AcuitySeveritiesAdverse EventPrimary OutcomeSafetyToxic EffectPharmaceutical PreparationsChronicMediatingProspectiveClinical TrialsLettersSamplingResponseClinic
Grant awards (51)
Studies of Ocular inflammation: Clinical & Translational Research$2,024,018
ZIA · FY2020 · EY · contact PI
Uveitis and Ocular Immunology Fellowship$614,225
ZIE · FY2020 · EY · contact PI
Studies of Ocular inflammation: Clinical & Translational Research$1,451,376
ZIA · FY2019 · EY · contact PI
Uveitis and Ocular Immunology Fellowship$385,565
ZIE · FY2019 · EY · contact PI
Studies of Ocular inflammation: Clinical research$802,646
ZIA · FY2018 · EY · contact PI
Uveitis and Ocular Immunology Fellowship$408,125
ZIE · FY2018 · EY · contact PI
Studies of Ocular inflammation: Clinical research$1,194,518
ZIA · FY2017 · EY · contact PI
Uveitis and Ocular Immunology Fellowship$170,645
ZIE · FY2017 · EY · contact PI
Diagnosis And Treatment Of Ocular Inflammatory Disease (uveitis)$286,009
ZIA · FY2016 · EY · contact PI
Uveitis and Ocular Immunology Fellowship$170,556
ZIE · FY2016 · EY · contact PI
Uveitis/Intraocular Inflammatory Disease Biobank (iBank) (16-EI-0046)$157,436
ZIA · FY2016 · EY · contact PI
Microbiome and Ocular Inflammatory Disease$144,317
ZIA · FY2016 · EY · contact PI
Multicenter uveitis trial using a steroid implant and inflammatory mediators$110,205
ZIA · FY2016 · EY · contact PI
Gevokizumab Treatment for Active Scleritis By IL-1 Inhibition (GATSBY)$70,846
ZIA · FY2016 · EY · contact PI
PeriOcular & Intravitreal Corticosteroids for Uveitic Macular Edema (POINT) Trial (16-EI-0102)$47,231
ZIA · FY2016 · EY · contact PI
Immunogenetic mechanisms in Behcet's Disease$34,111
ZIA · FY2016 · EY · contact PI
LI/NEI Repository Protocol$5,248
ZIA · FY2016 · EY · contact PI
Uveitis and Ocular Immunology Fellowship$164,541
ZIE · FY2015 · EY · contact PI
Gevokizumab Treatment for Active Scleritis By IL-1 Inhibition (GATSBY)$141,035
ZIA · FY2015 · EY · contact PI
Immunogenetic mechanisms in Behcet's Disease$72,868
ZIA · FY2015 · EY · contact PI
Subconjunctival Sirolimus for Active Anterior Scleritis (12-EI-0057)$56,414
ZIA · FY2015 · EY · contact PI
Multicenter uveitis trial using a steroid implant and inflammatory mediators$49,362
ZIA · FY2015 · EY · contact PI
Rituximab for Autoimmune Retinopathy$47,012
ZIA · FY2015 · EY · contact PI
Uveitis and Ocular Immunology Fellowship$164,868
ZIE · FY2014 · EY · contact PI
Gevokizumab Treatment for Active Scleritis By IL-1 Inhibition (GATSBY)$133,350
ZIA · FY2014 · EY · contact PI
Subconjunctival Sirolimus for Active Anterior Scleritis (12-EI-0057)$94,557
ZIA · FY2014 · EY · contact PI
Multicenter uveitis trial using a steroid implant and inflammatory mediators$50,915
ZIA · FY2014 · EY · contact PI
Rituximab for Autoimmune Retinopathy$43,642
ZIA · FY2014 · EY · contact PI
Immunogenetic mechanisms in Behcet's Disease$31,519
ZIA · FY2014 · EY · contact PI
Treatment of Uveitic Macular Edema with Intravitreal Methotrexate (11-ei-0107)$24,245
ZIA · FY2014 · EY · contact PI
Uveitis and Ocular Immunology Fellowship$172,566
ZIE · FY2013 · EY · contact PI
Subconjunctival Sirolimus for Active Anterior Scleritis (12-EI-0057)$115,832
ZIA · FY2013 · EY · contact PI
Rituximab for Autoimmune Retinopathy$47,278
ZIA · FY2013 · EY · contact PI
Immunogenetic mechanisms in Behcet's Disease$30,731
ZIA · FY2013 · EY · contact PI
Treatment of Uveitic Macular Edema with Intravitreal Methotrexate (11-ei-0107)$28,367
ZIA · FY2013 · EY · contact PI
Topical Interferon Gamma for Uveitic macular edema (JAKSTAT2: 11-EI-0167)$2,364
ZIA · FY2013 · EY · contact PI
Uveitis and Ocular Immunology Fellowship$197,242
ZIE · FY2012 · EY · contact PI
Subconjunctival Sirolimus for Active Anterior Scleritis (12-EI-0057)$116,884
ZIA · FY2012 · EY · contact PI
Rituximab for Autoimmune Retinopathy$48,702
ZIA · FY2012 · EY · contact PI
Immunogenetic mechanisms in Behcet's Disease$29,221
ZIA · FY2012 · EY · contact PI
Treatment of Uveitic Macular Edema with Intravitreal Methotrexate (11-ei-0107)$26,786
ZIA · FY2012 · EY · contact PI
Subconjunctival Sirolimus for the Treatment of Autoimmune Active Anterior Uveitis$21,916
ZIA · FY2012 · EY · contact PI
Topical Interferon Gamma for Uveitic macular edema (JAKSTAT2: 11-EI-0167)$2,435
ZIA · FY2012 · EY · contact PI
Uveitis and Ocular Immunology Fellowship$304,837
ZIE · FY2011 · EY · contact PI
Subconjunctival Sirolimus for the Treatment of Autoimmune Active Anterior Uveitis$65,556
ZIA · FY2011 · EY · contact PI
Rituximab for Autoimmune Retinopathy$65,556
ZIA · FY2011 · EY · contact PI
Immunogenetic mechanisms in Behcet's Disease$52,445
ZIA · FY2011 · EY · contact PI
Uveitis and Ocular Immunology Fellowship$318,407
ZIE · FY2010 · EY · contact PI
Subconjunctival Sirolimus for the Treatment of Autoimmune Active Anterior Uveitis$62,433
ZIA · FY2010 · EY · contact PI
Rituximab for Autoimmune Retinopathy$62,433
ZIA · FY2010 · EY · contact PI
Uveitis and Ocular Immunology Fellowship$404,245
ZIE · FY2009 · EY · contact PI